Á lódáil...
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart(®) in patients with multiple sclerosis
BACKGROUND: Adherence to disease-modifying drugs (DMDs) is one of the key factors for achieving optimal clinical outcomes. Rebismart(®) is an injection device for subcutaneous administration of interferon beta-1a (INF β-1a) that is also able to monitor adherence objectively. The aim of this study wa...
Na minha lista:
Foilsithe in: | Patient Prefer Adherence |
---|---|
Main Authors: | , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Dove Medical Press
2017
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5338953/ https://ncbi.nlm.nih.gov/pubmed/28280313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S127508 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|